Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation
Tóm tắt
It is now clear that functionally specialized regulatory T (Treg) cells exist as part of the normal immune repertoire, preventing the development of pathogenic responses to both self- and intestinal antigens. Here, we report that the Treg cells that control intestinal inflammation express the same phenotype (CD25+CD45RBlowCD4+) as those that control autoimmunity. Previous studies have failed to identify how CD25+ Treg cells function in vivo. Our studies reveal that the immune-suppressive function of these cells in vivo is dependent on signaling via the negative regulator of T cell activation cytotoxic T lymphocyte–associated antigen 4 (CTLA-4), as well as secretion of the immune-suppressive cytokine transforming growth factor β. Strikingly, constitutive expression of CTLA-4 among CD4+ cells was restricted primarily to Treg cells, suggesting that CTLA-4 expression by these cells is involved in their immune-suppressive function. These findings raise the possibility that Treg cell function contributes to the immune suppression characteristic of CTLA-4 signaling. Identification of costimulatory molecules involved in the function of Treg cells may facilitate further characterization of these cells and development of new therapeutic strategies for the treatment of inflammatory diseases.
Từ khóa
Tài liệu tham khảo
Tlaskalova, 1970, The immune response of germ-free piglets after peroral monocontamination with living Escherichia coli strain 086. I. The fate of antigen, dynamics and site of antibody formation, nature of antibodies and formation of heterohaemagglutinins, Folia Biol. (Praha)., 16, 177
Powrie, 1995, T cells in inflammatory bowel diseaseprotective and pathogenic roles, Immunity., 3, 171, 10.1016/1074-7613(95)90086-1
Powrie, 1993, Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice, Int. Immunol., 5, 1461, 10.1093/intimm/5.11.1461
Morrissey, 1993, CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells, J. Exp. Med., 178, 237, 10.1084/jem.178.1.237
Leach, 1996, Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells, Am. J. Pathol., 148, 1503
Powrie, 1994, Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells, Immunity., 1, 553, 10.1016/1074-7613(94)90045-0
Powrie, 1997, CD4+ T-cells in the regulation of inflammatory responses in the intestine, Res. Immunol., 148, 576, 10.1016/S0923-2494(98)80152-1
Aranda, 1997, Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients, J. Immunol., 158, 3464, 10.4049/jimmunol.158.7.3464
Powrie, 1996, A critical role for transforming growth factor β but not interleukin 4 in the suppression of T helper type 1–mediated colitis by CD45RBlow CD4+ T cells, J. Exp. Med., 183, 2669, 10.1084/jem.183.6.2669
Asseman, 1999, An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation, J. Exp. Med., 190, 995, 10.1084/jem.190.7.995
Fowell, 1993, Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential, J. Exp. Med., 177, 627, 10.1084/jem.177.3.627
Saoudi, 1996, The physiological role of regulatory T cells in the prevention of autoimmunitythe function of the thymus in the generation of the regulatory T cell subset, Immunol. Rev., 149, 195, 10.1111/j.1600-065X.1996.tb00905.x
Sakaguchi, 1985, Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease, J. Exp. Med., 161, 72, 10.1084/jem.161.1.72
Sakaguchi, 1995, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J. Immunol., 155, 1151, 10.4049/jimmunol.155.3.1151
Suri-Payer, 1998, CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells, J. Immunol., 160, 1212, 10.4049/jimmunol.160.3.1212
Asano, 1996, Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation, J. Exp. Med., 184, 387, 10.1084/jem.184.2.387
Thornton, 1998, CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production, J. Exp. Med., 188, 287, 10.1084/jem.188.2.287
Takahashi, 1998, Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cellsinduction of autoimmune disease by breaking their anergic/suppressive state, Int. Immunol., 10, 1969, 10.1093/intimm/10.12.1969
Van Parijs, 1998, Homeostasis and self-tolerance in the immune systemturning lymphocytes off, Science., 280, 243, 10.1126/science.280.5361.243
Lanzavecchia, 2000, From synapses to immunological memorythe role of sustained T cell stimulation, Curr. Opin. Immunol., 12, 92, 10.1016/S0952-7915(99)00056-4
Shahinian, 1993, Differential T cell costimulatory requirements in CD28-deficient mice, Science., 261, 609, 10.1126/science.7688139
Allison, 1994, CD28-B7 interactions in T-cell activation, Curr. Opin. Immunol., 6, 414, 10.1016/0952-7915(94)90120-1
June, 1994, The B7 and CD28 receptor families, Immunol. Today., 15, 321, 10.1016/0167-5699(94)90080-9
Walunas, 1996, CTLA-4 ligation blocks CD28-dependent T cell activation, J. Exp. Med., 183, 2541, 10.1084/jem.183.6.2541
Krummel, 1996, CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells, J. Exp. Med., 183, 2533, 10.1084/jem.183.6.2533
Perez, 1997, Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement, Immunity., 6, 411, 10.1016/S1074-7613(00)80284-8
Leach, 1996, Enhancement of antitumor immunity by CTLA-4 blockade, Science., 271, 1734, 10.1126/science.271.5256.1734
Karandikar, 1996, CTLA-4a negative regulator of autoimmune disease, J. Exp. Med., 184, 783, 10.1084/jem.184.2.783
Perrin, 1996, CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis, J. Immunol., 157, 1333, 10.4049/jimmunol.157.4.1333
Luhder, 1998, Cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes, J. Exp. Med., 187, 427, 10.1084/jem.187.3.427
Waterhouse, 1995, Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4, Science., 270, 985, 10.1126/science.270.5238.985
Tivol, 1995, Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4, Immunity., 3, 541, 10.1016/1074-7613(95)90125-6
Chen, 1998, Engagement of cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+ T cells, J. Exp. Med., 188, 1849, 10.1084/jem.188.10.1849
Coffman, 1982, Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development, Immunol. Rev., 69, 5, 10.1111/j.1600-065X.1983.tb00446.x
Oosterwegel, 1999, The role of CTLA-4 in regulating Th2 differentiation, J. Immunol., 163, 2634, 10.4049/jimmunol.163.5.2634
Chambers, 1999, Costimulatory regulation of T cell function, Curr. Opin. Cell Biol., 11, 203, 10.1016/S0955-0674(99)80027-1
Linsley, 1996, Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement, Immunity., 4, 535, 10.1016/S1074-7613(00)80480-X
Alegre, 1996, Regulation of surface and intracellular expression of CTLA4 on mouse T cells, J. Immunol., 157, 4762, 10.4049/jimmunol.157.11.4762
Krummel, 1995, CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation, J. Exp. Med., 182, 459, 10.1084/jem.182.2.459
Walunas, 1994, CTLA-4 can function as a negative regulator of T cell activation, Immunity., 1, 405, 10.1016/1074-7613(94)90071-X
Metzler, 1999, Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo, Int. Immunol, 11, 667, 10.1093/intimm/11.5.667
Takahashi, 2000, Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte–associated antigen 4, J. Exp. Med., 192, 303, 10.1084/jem.192.2.303
McCoy, 1997, Protective immunity to nematode infection is induced by CTLA-4 blockade, J. Exp. Med., 186, 183, 10.1084/jem.186.2.183
Bachmann, 1999, Cutting edgelymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous, J. Immunol., 163, 1128, 10.4049/jimmunol.163.3.1128
Read, 1998, CD38+ CD45RBlow CD4+ T cellsa population of T cells with immune regulatory activities in vitro, Eur. J. Immunol., 28, 3435, 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.0.CO;2-P